| Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases P Elliott, B Andersson, E Arbustini, Z Bilinska, F Cecchi, P Charron, ... European heart journal 29 (2), 270-276, 2008 | 3991 | 2008 |
| Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on … ALP Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, ... European heart journal 34 (33), 2636-2648, 2013 | 3436 | 2013 |
| 2015 ESC Guidelines for the diagnosis and management of pericardial diseases Y Adler, P Charron, M Imazio, L Badano, G Barón-Esquivias, J Bogaert, ... Polish Heart Journal (Kardiologia Polska) 73 (11), 1028-1091, 2015 | 2709 | 2015 |
| Guidelines on the diagnosis and management of pericardial diseases executive summary: the Task Force on the Diagnosis and Management of Pericardial Diseases of the European … B Maisch, PM Seferović, AD Ristić, R Erbel, R Rienmüller, Y Adler, ... European heart journal 25 (7), 587-610, 2004 | 1445 | 2004 |
| Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. WG Daniel, R Erbel, W Kasper, CA Visser, R Engberding, GR Sutherland, ... Circulation 83 (3), 817-821, 1991 | 1018 | 1991 |
| European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis … AL Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, SB Felix, ... Eur Heart J 34 (33), 2636-48, 2013 | 658 | 2013 |
| Guidelines for the study of familial dilated cardiomyopathies L Mestroni, B Maisch, WJ McKenna, K Schwartz, P Charron, C Rocco, ... European heart journal 20 (2), 93-102, 1999 | 633 | 1999 |
| Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study W Grimm, M Christ, J Bach, HH Müller, B Maisch Circulation 108 (23), 2883-2891, 2003 | 475 | 2003 |
| Increased osteoprotegerin serum levels in men with coronary artery disease M Schoppet, AM Sattler, JR Schaefer, M Herzum, B Maisch, LC Hofbauer The Journal of Clinical Endocrinology & Metabolism 88 (3), 1024-1028, 2003 | 465 | 2003 |
| Task Force on the diagnosis and management of pricardial diseases of the European Society of Cardiology B Maisch Eur Heart J 25, 587-610, 2004 | 464 | 2004 |
| A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb ... New England Journal of Medicine 335 (11), 775-782, 1996 | 446 | 1996 |
| International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina E Topol, R Califf, F Van de Werf, R Diaz, E Paolasso, P Aylward, J Simes, ... Circulation 97 (24), 2386-2395, 1998 | 441 | 1998 |
| A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy E Villard, C Perret, F Gary, C Proust, G Dilanian, C Hengstenberg, ... European heart journal 32 (9), 1065-1076, 2011 | 382 | 2011 |
| The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) First Epidemiological Results: First Epidemiological Results G Hufnagel, S Pankuweit, A Richter, U Schönian, B Maisch, ... Herz 25, 279-285, 2000 | 369 | 2000 |
| Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 M Spiecker, H Darius, T Hankeln, M Soufi, AM Sattler, JR Schaefer, ... Circulation 110 (15), 2132-2136, 2004 | 316 | 2004 |
| Definition of Inflammatory Cardiomyopathy (Myocarditis): On the Way to Consensus A Status Report: A Status Report B Maisch, I Portig, A Ristic, G Hufnagel, S Pankuweit Herz 25, 200-209, 2000 | 308 | 2000 |
| Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the … F Schulze, H Lenzen, C Hanefeld, A Bartling, KJ Osterziel, L Goudeva, ... American heart journal 152 (3), 493. e1-493. e8, 2006 | 294 | 2006 |
| Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Monckeberg’s sclerosis and … M Schoppet, N Al-Fakhri, FE Franke, N Katz, PJ Barth, B Maisch, ... The Journal of Clinical Endocrinology & Metabolism 89 (8), 4104-4112, 2004 | 279 | 2004 |
| The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial P Lechat, KW Brunhuber, R Hofmann, P Kuhn, HJ Nesser, J Slany, ... Lancet 353 (9146), 9-13, 1999 | 276 | 1999 |
| Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS) P Lechat, S Escolano, JL Golmard, H Lardoux, S Witchitz, JA Henneman, ... Circulation 96 (7), 2197-2205, 1997 | 268 | 1997 |